Anticorps spécifique des myosites Antibodies COVID-19 Middle Aged Myositis and muscle disease Adeno-associated vector Adverse drug reactions Biomarkers Antisynthétase Cytokines Cancer Aldosterone Adult Abnormal movement Antiphospholipid syndrome Sphingosine-1-phosphate Deep immune profiling B cell homeostasis Adeno-associated virus vector Biomarker Polymyositis Myositis Aged Auto‐antibodies Autoantibody Amyotrophy Machine learning Anti‐mitochondrial antibodies Anti-drug antibodies B-lymphocyte Agalsidase Autoantibodies Inborn errors of metabolism IBM Data integration Arthritis Autoimmune diseases Outcome measures Anti-synthetase syndrome Idiopathic inflammatory myopathies Gene therapy Interstitial lung disease Anti-interleukin-6 Anti-MDA5 autoantibodies Female Bioelectrical impedance analysis Acute Kidney Injury/epidemiology/etiology IMNM Systems biology Anémie hémolytique Myocarditis Adjudication Dependovirus/genetics/immunology Acid-alpha-glucosidase Immune checkpoint inhibitors Interferon Inflammatory myopathy Autoimmunity Muscle Anti-agalsidase antibodies Analyses multidimensionnelles DM Myopathy Anti-IgE IgG AAV humoral immunity Active Amyotrophic lateral sclerosis Dermatomyositis Anti-Mi2 Lysosomal storage diseases Anticorps anti-agalsidase Antisynthetase Adolescence AAV vector Antibody responses CD8+ T-bet+ cells CD8+T cells Multidisciplinarity Male Adeno-associated virus Antisynthetase syndrome Fabry disease Inflammation AAV Immunotherapy Biopsy Aldostérone Biomarqueurs Animals Mass cytometry AAV vectors Assisted communication devices Humans AAV antibody Skeletal muscle Auto-antibodies Auto-immunité Inclusion body myositis Case reports Prognosis